{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:11:57Z","timestamp":1778659917027,"version":"3.51.4"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/mcg.0b013e3181945942","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T12:38:17Z","timestamp":1242909497000},"page":"496-498","source":"Crossref","is-referenced-by-count":20,"title":["Fatal Reactivation of Hepatitis B Virus in a Patient Who Was Hepatitis B Surface Antigen Negative and Core Antibody Positive Before Receiving Chemotherapy for Non-Hodgkin Lymphoma"],"prefix":"10.1097","volume":"43","author":[{"given":"Jia-Min","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pui-Ching","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210305","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J Viral Hepat"},{"key":"R2-19-20210305","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00277-008-0469-9","article-title":"High prevalence of occult hepatitis B virus infection in patient with B cell non-Hodgkin's lymphoma","volume":"87","author":"Chen","year":"2008","journal-title":"Ann Hematol"},{"key":"R3-19-20210305","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hon.2900080504","article-title":"Hepatitis B infection in patients with lymphomas","volume":"8","author":"Liang","year":"1990","journal-title":"Hematol Oncol"},{"key":"R4-19-20210305","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2006.10.007","article-title":"Occult hepatitis B virus infection","volume":"46","author":"Raimondo","year":"2007","journal-title":"J Hepatol"},{"key":"R5-19-20210305","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1053\/j.gastro.2008.02.017","article-title":"The characteristic of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection","volume":"134","author":"Zerbini","year":"2008","journal-title":"Gastroenterology"},{"key":"R6-19-20210305","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"R7-19-20210305","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.21051","article-title":"Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy","volume":"43","author":"Yeo","year":"2006","journal-title":"Hepatology"},{"key":"R8-19-20210305","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.cld.2007.08.006","article-title":"Antiviral porphylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection","volume":"11","author":"Kohrt","year":"2007","journal-title":"Clin Liver Dis"},{"key":"R9-19-20210305","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.blre.2008.02.001","article-title":"Management of viral hepatitis in hematologic malignancies","volume":"22","author":"Firpi","year":"2008","journal-title":"Blood Rev"},{"key":"R10-19-20210305","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/jac\/dki114","article-title":"Lamivudine prophylaxis in HBV carriers with haemato-oncological malignancies who receive chemotherapy.","volume":"55","author":"Idilman","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"R11-19-20210305","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(75)80054-0","article-title":"Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders","volume":"68","author":"Wands","year":"1975","journal-title":"Gastroenterology"},{"key":"R12-19-20210305","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-G","article-title":"Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study","volume":"100","author":"Lok","year":"1991","journal-title":"Gastroenterology"},{"key":"R13-19-20210305","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0399-8320(07)78326-4","article-title":"Fatal liver failure after hepatitis B reactivation following chemotherapy for lymphoma in a patient with only anti-HBc antibody and review of the literature","volume":"31","author":"Thirot-Bidault","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"R14-19-20210305","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","article-title":"Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy","volume":"17","author":"Czuczman","year":"1999","journal-title":"J Clin Oncol"},{"key":"R15-19-20210305","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10156-005-0385-Z","article-title":"HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb.","volume":"11","author":"Sarrecchia","year":"2005","journal-title":"J Infect Chemother"},{"key":"R16-19-20210305","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/10428190500062932","article-title":"Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations.","volume":"46","author":"Law","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"R17-19-20210305","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/hep.22106","article-title":"A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial","volume":"47","author":"Hsu","year":"2008","journal-title":"Hepatology"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004836-200905000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:22:55Z","timestamp":1618035775000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-200905000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e3181945942","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}